| 000 | 01002 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512114630.0 | ||
| 264 | 0 | _c19740322 | |
| 008 | 197403s 0 0 dan d | ||
| 022 | _a0041-5782 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVidebaek, A | |
| 245 | 0 | 0 |
_a[Immunosuppressive therapy. A survey concerning rationale, risks, indications and contraindications]. _h[electronic resource] |
| 260 |
_bUgeskrift for laeger _cOct 1973 |
||
| 300 |
_a2372-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAzathioprine _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune System Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms _xchemically induced |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 773 | 0 |
_tUgeskrift for laeger _gvol. 135 _gno. 44 _gp. 2372-7 |
|
| 999 |
_c4594111 _d4594111 |
||